• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Congo Red Dot Paper Test: Can it be Used to Diagnose Preeclampsia?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Previous research from this group showed that in preeclampsia, an underlying mechanism may be a protein conformational disorder (abnormal changes in protein size or shape)
  • Proteins in the urine of preeclamptic women bind to Congo Red dye, resulting in a phenomenon known as urine congophilia
  • Rood et al. (Lancet E Clinical Medicine, 2019) assessed the utility of a paper-based point-of-care test to detect congophilia for rapid preeclampsia triage and diagnosis

METHODS:

  • Prospective cohort study
  • Participants
    • Pregnant women evaluated for PE in L&D triage
  • Study design
    • Congo Red Dot (CRD) Paper Test (index test) was performed on fresh urine samples
    • CRD Paper Test results were compared to an expert adjudicated diagnosis in each case (2 MFMs blinded to results)
    • Accuracy of the CRD Paper Test was also compared to other urine and serum analytes relevant to preeclampsia diagnosis  
      • Placental growth factor (PlGF)
      • Soluble fms-like tyrosine kinase-1 (sFlt-1)

RESULTS:

  • 346 women
    • Clinical diagnosis of PE in triage: 32%
    • Admitted for PE workup: 63%
  • CRD Paper Test
    • Positive: 25%
    • Adjudication confirmed: 28%
  • CRD Paper Test performance
    • 80.2% sensitivity
    • 89.2% specificity
    • 92.1% negative predictive value
    • 86.7% accuracy
  • While pre-test probability was 27.7%, following testing
    • PPV: 74.0%
    • NPV: 92.1%
  • CRD Paper Test outperformed measured serum and urine markers, based on the following AUC ROC data
    • CRD Paper Test: 0.850 (95% CI, 0.808 to 0.886)
    • sFlt-1: Urine 0.723 [95% CI, 0.673 to 0.770) | Serum 0.809 (95% CI, 0.753 to 0.856)
    • PlGF:  Urine 0.678 (95%. CI, 0.625 to 0.727) | Serum 0.474 (95% CI, 0.687 to 0.801)
    • Urine sFlt-1/PlGF: 0.765 (95% CI, 0.716 to 0.809)

CONCLUSION:

  • The CRD Paper Test outperformed previous diagnostic markers for preeclampsia
  • The authors state that

CRD Paper Test is an accurate, low technology, easy to use triage diagnostic tool that allows for accurate identification of PE within minutes

Learn More – Primary Sources:

Congo Red Dot Paper Test for Antenatal Triage and Rapid Identification of Preeclampsia

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Try it Free  »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Which Markers Can We Use to Screen for Early and Late Preeclampsia?
Does Placental Growth Factor Lead to a Quicker Diagnosis in Women with Suspected Pre-Eclampsia?
How Well Can Uric Acid Levels Predict Preeclampsia Complications?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site